Evidence map›Paper›PMID 31673243›Full record

ArticleInternational journal of medical sciences2019

SiRNA-Mediated

Ting Xue, Liming Wang, Yong Li, Hao Song, Huijun Chu, Hongjuan Yang, Ailian Guo, Jinwen Jiao

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Interplay between altered metabolism and DNA damage and repair in ovarian cancer.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ting XueQingdao University, Qingdao, China.
Liming WangDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yong LiDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Hao SongDepartment of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Huijun ChuDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Hongjuan YangDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Ailian GuoQingdao University, Qingdao, China.
Jinwen JiaoDepartment of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qingdao University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisCarcinoma, Ovarian EpithelialCell Line, TumorCell ProliferationCisplatinCombined Modality TherapyDrug Resistance, NeoplasmFemaleGene SilencingHumansMiceRibonucleoside Diphosphate ReductaseRNA, Small InterferingTransfectionCisplatinRibonucleoside Diphosphate Reductaseribonucleotide reductase M2RNA, Small Interferingcisplatinnude miceovarian cancerRRM2siRNA/RNAi

Identifiers

PMID31673243
PMCPMC6818211
OpenAlexW2982579575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.